| Name | Oxford Biodynamics |
|---|---|
| Epic | OBD |
| Isin | GB00BD5H8572 |
| Index | AIM100 AIM350 |
| Industry |
| Latest share price | 1.16p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £3.63 | Debt ratio | n/a |
| Shares in issue | 311.86 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -102.54 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -7.3 | 52-week high / low | 1.12p / 34.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Oxford Biodynamics |
|---|---|
| Address | 3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, United Kingdom, OX4 2WB |
| Telephone | +44 (0)1865 518 910 |
| Website | http://www.oxfordbiodynamics.com/ |
| Director | Position |
|---|---|
| Mr Stephen Charles Diggle | Non-Executive Director |
| Mr Matthew Wakefield | Non-Executive Chairman |
| Dr Jon Burrows | Chief Executive Officer |
| Dr David Holbrook | Independent Non-Executive Director |
| Dr Alexandre Akoulitchev | Chief Scientific Officer |
| Mr Paul Stockdale | CFO & Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 30/09/23 | 30/09/22 | 30/09/21 |
| Intangible asssets and goodwill | 1.91 | 1.6 | 1.15 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 8.96 | 8.58 | 8.7 |
| Inventory / work in progress | 0.27 | 0.34 | 0.39 |
| Trade and other receivables | 1.64 | 1.43 | 1.95 |
| Cash and equivalents | 5.25 | 0.97 | 2.17 |
| Other current assets and asset held for resale | n/a | 0.03 | 2.16 |
| Total of all assets | 16.13 | 11.34 | 15.38 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 4 | 2.91 | 2.3 |
| Long term liabilities | 6.07 | 5.85 | 6.39 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 10.07 | 8.76 | 8.69 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 6.05 | 2.59 | 6.69 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 2.02 | 1 | 0.93 |
| Minority interests | n/a | n/a | 0.02 |
| Retained earnings | -30.82 | -20.71 | -14.17 |
| Share premium account | 32.14 | 19.02 | 16.74 |
| Total equity | 6.05 | 2.59 | 6.69 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -10.17 | -8.6 | -7.51 |
| Pre-tax profit | -11.41 | -7.57 | -7.63 |